| Literature DB >> 29449558 |
Salina Ahmed1, Liz Steed2, Katherine Harris1, Stephanie J C Taylor1, Hilary Pinnock3.
Abstract
South Asian and other minority communities suffer poorer asthma outcomes, have a higher rate of unscheduled care and benefit less from most existing self-management interventions when compared to the majority population. Possible reasons for these differences include failure to implement asthma self-management strategies, or that strategies implemented were inappropriate for their needs; alternatively, they may relate to the minority and/or lower socioeconomic status of these populations. We aimed to synthesise evidence from randomised controlled trials for asthma self-management in South Asian and Black populations from different sociocultural contexts, and identify barriers and facilitators to implementing self-management. We systematically searched eight electronic databases, and research registers, and manually searched relevant journals and reference lists of reviews. Seventeen trials met the inclusion criteria and were analysed narratively. We found two culturally targeted interventions compared to fifteen culturally modified interventions. Interventions used diverse self-management strategies; education formed a central component. Interventions in South Asian and African-American minority communities were less effective than interventions delivered in indigenous populations in South Asia, though the latter trials were at higher risk of bias. Education, with continuous professional support, was common to most interventions. Facilitators to asthma self-management included: ensuring culturally/linguistically appropriate education, adapting to learning styles, addressing daily stressors/social support and generic self-management strategies. In conclusion, when developing and evaluating self-management interventions aimed at different cultures, the influence of sociocultural contexts (including whether patients are from a minority or indigenous population) can be important for the conceptualisation of culture and customisation of self-management strategies.Entities:
Mesh:
Year: 2018 PMID: 29449558 PMCID: PMC5814446 DOI: 10.1038/s41533-017-0070-6
Source DB: PubMed Journal: NPJ Prim Care Respir Med ISSN: 2055-1010 Impact factor: 2.871
Definition of terms
| Term | Definition | Examples |
|---|---|---|
| Culturally modified/adapted interventions[ | Pre-existing generic interventions modified for the intention of being relevant to ethnic groups using various strategies, though the content is primarily the same | Language translation, and use of images and bilingual educators from a similar ethnicity as the target population |
| Culturally targeted interventions[ | A bottom-up process which considers the shared characteristics and dimensions of collective individuals of a culture before developing an intervention, aimed at a group level | Religion |
| Culturally tailored interventions[ | A bottom-up process which considers the unique cultural characteristics and dimensions of individuals within a cultural group before developing an intervention, aimed at individuals within a group | Level of religious identification or spirituality |
| ‘Majority’ South Asians | Interventions from South Asian countries where the population forms a majority | South Asians in India |
| ‘Minority’ South Asians; ‘Minority’ African Americans | Interventions from countries where the population forms a minority | South Asians in the UK or Canada; African Americans in the USA |
Fig. 1PRISMA flow diagram
Overview of study characteristics of included trials
| Study, Country | Population characteristics | Intervention characteristics | ||||||
|---|---|---|---|---|---|---|---|---|
| Aim | Ethnicity; Participants; Sample age; Sample size ( | Study setting; SES/area | Intervention description/length | Control /other group descriptions | Delivery (ethnicity; language) | Mode of delivery | Modified; Targeted; Tailored | |
| ‘Majority’ South Asian trials | ||||||||
| Agrawal[ | Evaluated efficacy of PAAPSs for asthma control | Indian; Patients; parents; 2–12; 60 (32/28) | Tertiary (university clinic) | Education; sessions, training including on asthma symptom diary and peak flow measurements | No PAAP, standard asthma therapy and education | Trained physician; social scientist (-) | Individual; Written material | Modified |
| – | PAAPs | |||||||
| Asthma therapy/not stated | ||||||||
| Behera[ | Assessed patient knowledge of self-care needs and develop/evaluate a self-care manual | Indian | Tertiary (outpatient university clinic) | Education-booklet in Hindi (included a PAAP) | No specific instructions/pilot study used to develop booklet in Hindi ( | Not stated (Hindi) | Written material | Targeted |
| Patients; 18–60; 523 (260/263) | – | Booklet evaluation/not stated | Other methods not stated | |||||
| Ghosh[ | Assessed the impact of self-management education and training on health status and resource use |
| Tertiary (university clinic) | Education; sessions, training, written instructions, audio-visual aids, role models, group/scenario discussions | Regular care e.g. drug administration | Trained social scientist (-) | Group; | Modified |
| Patients; Parents; 10–45; 276 (140/136) | – | Daily diary (included symptom assessment and financial workbook) | Written material | |||||
| Asthma therapy | ||||||||
| Shanmugam[ | Provided pharmaceutical care through partnership of pharmacists and patients for good asthma control | Indian | Tertiary (university hospital) | Education; sessions, asthma care diary in English and Tamil (including leaflet), PAAP and symptom log sheet | No pharmaceutical care | Not stated (English and Tamil) | Written material; | Modified |
| Patients Age; −; 66 (33/33) | – | Medication counselling/not stated | Other methods not stated | |||||
| ‘Minority’ South Asians trials | ||||||||
| Griffiths[ | Tested whether specialist nurses across ethnically diverse and deprived areas reduce unscheduled care | South Asians (mostly Bangladeshi) White Caucasians, Other (Black/African Caribbean/Other) | Primary/secondary (out-of-hours GP service/hospital) | Education; training based on guidelines, nurse review with advice | Usual care; single nurse visits to discuss asthma guidelines and check inhaler technique | Trained nurse specialists (partially; PAAPs explained in Sylheti) | Individual; | Modified |
| PAAP explained in English and Sylheti | Written material; | |||||||
| Ongoing clinical support for professionals on computer prompts | ||||||||
| Patients; 4–60; 164 (95/69) | Deprived/urban | Peak flow meters provided | Telephone | |||||
| Oral corticosteroids/2 one hour visits for GP practices; 194 days | ||||||||
| Griffiths[ | Tested whether culturally specific education programmes adapted from USA interventions reduce unscheduled care | South Asians (Bangladeshi, Pakistani, Indian, Sri Lankan) | Primary (GP) | Education; session including PAAP, nurse follow-ups to book appointments (CDSMP), research training with video based on guidelines, South Asian actors and manualised programme (PACE)/PACE; two seminars; CDSMP; 2-hour session | Usual care; nurse delivered standardised consultation. No PAAP/follow-up appointments provided | PACE; Nurse specialists, Academic GPs CDSMP; Trained nurse specialists (South Asians) | Group; | Modified |
| Patients; Primary/secondary care clinicians; 3 and above; 375 (183/192) | Deprived/urban | Video/DVD; | ||||||
| Written material | ||||||||
| Moudgil[ | Tested whether bilingual education of treatment optimisation and follow-up reduce urgent healthcare and improve quality of life | South Asian (mainly Indian and Pakistani), White European | Primary (GP) | Education; community sessions delivered in South Asian languages including written literature, education follow-up | Usual asthma care follow-up | Trained GP (South Asian) | Individual; | Modified |
| Patients; GP; 11–59; 344 (171/173) | Low or medium deprivation/urban | Booklet including PAAP (based on BTS guidelines) and peak flow measurements | Written material | |||||
| GP trained on prescribing, optimal treatment, knowledge and medication | ||||||||
| Peak flow meter provided | ||||||||
| Asthma therapy/40 minutes | ||||||||
| Poureslami[ | Explored the effectiveness of different culturally relevant information formats and impact on self-management | South Asians (Indian Punjabi), Chinese | Other/tertiary (home, university clinic)- | Education; videos (physician-led, community and physician-led/community combination) | Pictorial pamphlet in either Mandarin, Cantonese or Punjabi | Research facilitators (South Asian) | Group/video | Targeted |
| Patients; 21 and above; 45 (33/12) | Peak flow meter | /Co-development of intervention ( | ||||||
| PAAPs/1 month | ||||||||
| ‘Minority’ African American trials | ||||||||
| Blixen[ | Tested feasibility of a culturally appropriate in-patient education programme for hospitalisation | African Americans | Tertiary (hospital) | Education; sessions and video, asthma workbook using African-American images, references to famous celebrities, written education posted as follow-up | Received usual care | Trained nurse (Not stated) | Individual; | Modified |
| Patients; 8–50; 28 (14/14) | – | Peak flow meter; MDI spacer provided | Video/DVD; | |||||
| Toll free numbers for asthma organisations/Three 1-hour sessions | Written material | |||||||
| Fisher[ | Tested community-based intervention to improve asthma awareness, attitudes, management practices and reduce acute care | African Americans, White Caucasians, Others | Other (community, school) | Education; promotion campaigns, sessions, training residents to support patients in school and community/12 months | Four areas in the same location with similar SES characteristics | Trained university staff/residents (African American) | Group; | Modified |
| Patients; parents 5–14; 249 (100/149) | Low income | Individual | ||||||
| Fisher[ | Tested whether community health workers can reach low-income parents of hospitalised children and to reduce rehospitalisation | African American | Other/secondary (community, hospital) | Education; sessions by asthma coach based on guidelines and parental support contacts/meetings for readiness to change, training for asthma coaches (including PAAPs)/2 years | Usual care; inpatient education and discharge planning with PAAP, a suggested follow-up primary care within 1 week of discharge | Nurse, | Individual; | Modified |
| Parents; African-American Coaches; 2–8; 191 (97/94) | Low income/urban | psychologist, | Group; | |||||
| three trained coaches (African American) | Telephone | |||||||
| Ford[ | Reanalysed an education programme that assessed the effects on asthma outcomes | African Americans | Secondary (emergency department) | Education; sessions and follow-ups, handout, mailed sessions for non-attenders | Received no intervention | Trained healthcare professionals and nurses (not stated) | Group; | Modified |
| Patients; 18–70; 241 (119/122) | Urban and rural | Visual medical card | Written material | |||||
| Wallet sized card (with medication list, dose, frequency) | ||||||||
| Placebo inhaler to practice/3 sessions | ||||||||
| Keslo[ | Provided major long-term therapeutic intervention and intensive education | African Americans | Secondary /tertiary (emergency department/university clinic) | Education; sessions based on NIH guidelines, Follow-up clinics | Usual care | Pharmacy researcher, pulmonologist (not stated) | Individual; | Modified |
| Patients; 18 and above; 52 (30/22) | Low; deprived | Telephone; | ||||||
| Education booklet (including diary card for measurements and 1-page summary of asthma prevention, medications, triggers and peak flow meter product literature) | Written material | |||||||
| Asthma therapy for ICS | ||||||||
| Peak flow meter (colour-coded stickers), inhaled b-agonist and aero chamber provided/1-hour session | ||||||||
| Keslo[ | Tested if a long‐term management programme (emphasising ICS and patient education), would improve outcomes | African Americans | Tertiary (university based clinic) | Education; session | Usual care from local physicians | Pharmacy researcher (not stated) | Individual; | Modified |
| Patients; 18 and above; 39 (21/18) | Low; working and middle-class college students | Educational booklet | Group; | |||||
| Written instructions on asthma crisis management | Written material | |||||||
| Asthma therapy and peak flow meter (colour-coded stickers), MDI and other medications | ||||||||
| Follow-up clinics (including diary)/2 years | ||||||||
| Velsor-Friedrich[ | Tested the effect of a school-based education programme (Open Airways) on the psychosocial outcomes | African Americans | Other | Education; sessions/2 weeks, six 45 minute sessions per week | Usual care; participated in the Open Airways programme after intervention | Academic professor, nurse | Group | Modified |
| Patients; 8–13; 102 (40/62) | (Eight public primary school with nurse clinics) | (-) | ||||||
| Low/Urban | ||||||||
| Velsor-Friedrich[ | An extension of the study above (Velsor-Friedrich 2004): tested a two-part school-based education programme | African Americans | Other (eight public primary schools with nurse clinics) | Education-sessions (as above) | As above and all students received a PAAP | Academic professor, academic nurse(-) | Individual; Written material | Modified |
| Patients; 8–13; 52 (28/24) | Low/urban | A further 5-month visit with nurse where education information was reinforced, a packet of asthma information reviewed if needed, PAAPs adjusted, clinical assessment on medication and peak flow monitoring/7 weeks, 45 minute sessions, once per week | ||||||
| Velsor-Friedrich[ | Evaluated efficacy of a school-based asthma education program on psychosocial & health outcomes | African Americans | Other (5 secondary schools) | Education; sessions, coping skills training including role-playing & technology use (with a booster session as follow-up) | Routine education | Clinician, | Individual; Group | Modified |
| Patients; 13–19; 137 (74/63) | Low | Nurse practitioner reinforcement & clinic visit | nurse, | |||||
| Provided MDI, hydro fluoroalkane & static free chamber | clinical psychologist | |||||||
| Peak flow diary | trained doctoral student | |||||||
| PAAP/Six 45 minute sessions over 6 weeks | (-) | |||||||
Note: Missing data obtained from authors is noted in italic in the table
All included paper findings as reported and the decisions underpinning the harvest plots
| Citation design, sample group/size and risk of bias score | Outcome categories, FU | Reported outcomes-values for intervention ( | Researcher’s interpretation for the harvest plot |
|---|---|---|---|
| Agrawal[ | Clinical-unscheduled care, 4 m | Compared to controls, children in the intervention group had: | Illustrated as a consistent significant positive effect |
| Fewer acute asthma events: | |||
| Overall risk of bias: Unclear | Clinical-asthma control, 4 m | Compared to controls, children in the intervention group had: | Illustrated as a consistent significant positive effect |
| Improved symptom score: (from the symptom diary) | |||
| Fewer nocturnal awakenings: | |||
| Reduced school absenteeism: | |||
| Process | Not assessed | – | |
| Behavioural | Not assessed | – | |
| Behera[ | Clinical-unscheduled care, 1 yr | A reduction in hospital admissions is illustrated graphically (the authors state that there was a significant decrease in hospital admissions in the intervention group at FU compared to the control group) | Illustrated as a consistent significant positive effect |
| FU: 2 wks, 6 m, 1 yr Overall risk of bias: high | Clinical-asthma control, 2 wks, 6 m, 1 yr | Symptom scores decreased in both groups | Illustrated as a consistent significant positive effect |
| Logistic regression: compared to the control group, more intervention group patients showed a significant improvement in symptom scores at 2 w, 6 m and 1 yr ( | |||
| Process, 2 wks, 6 m, 1 yr | Knowledge scores increased significantly in the intervention group and fell in the control group; | Illustrated as a consistent significant positive effect | |
| Logistic regression: Compared to the control group, more intervention group patients showed a significant increase in knowledge scores at 2 wks, 6 m and 1 yr ( | |||
| Behavioural, 2 wks, 6 m, 1 yr | Reported self-care in acute attacks showed no change in attitudes in either group, but significantly more patients in the intervention group adopted the recommended position (sitting, leaning forward) and practiced breathing exercises during an acute attack as compared to control patients | Illustrated as a significant positive effect but hatched to show inconsistency | |
| Ghosh[ | Clinical-unscheduled care, 1 yr (assessed by diary in months 4, 8 and 12) | Fewer total number of ED visits, but no between group difference in proportion with ED visit | Illustrated as positive but hatched to indicate inconsistency |
| Number of ED visits in the 3-month diary: | |||
| Proportion with ED visits in the 3-month diary: | |||
| Number and duration of hospitalisations were both significantly reduced | |||
| Hospital days in the three diary months: | |||
| Proportion hospitalised in the three diary months: | |||
| FU: 4 m, 8 m, 1 yr Overall risk of bias: high | Clinical-asthma control, 1 yr (assessed by diary in months 4, 8 and 12) | Fewer productive days lost in the intervention group during the three diary months | Illustrated as a consistent significant positive effect |
| Day lost: 17.6 (SD = 24.2)/34.1 (SD = 38.8); | |||
| PEFR was significantly improved in the intervention group relative to the control group; | |||
| Mean PEFR from diary cards | |||
| Process | Not assessed |
| |
| Behavioural | Not assessed |
| |
| Shanmugam[ | Clinical-unscheduled care | Not assessed |
|
| FU: 29 days Overall risk of bias: unclear | Clinical-asthma control, 29th day | Asthma control improved in the intervention group compared to the control group | Illustrated as a consistent significant positive effect |
| Mean ACT score for each question was greater in the intervention group at FU: | |||
| (Overall mean ACT scores are not reported) | |||
| Lung function showed a greater increase in the intervention group compared with control | |||
| PEFR (L/min): Baseline: | |||
| Process | Not assessed |
| |
| Behavioural | Not assessed |
| |
| Griffiths[ | Clinical-unscheduled care, 1 yr | [Note: these data are an | Illustrated as a consistent no effect |
| aTime to first unscheduled care effect on South Asians was not significant between intervention and control; South Asians HR 0.72, 0.48 to 1.09 | |||
| aProportion attending unscheduled asthma care: no between group differences in whole population. No data for South Asian sub-group, but authors state that ‘intervention effect was non-significant for other sub-group analysis’ | |||
| FU: 2 m, 9 m, 1 yr Overall risk of bias: low | Clinical-asthma control, 2 m, 1 yr | [Note: these data are an | Illustrated as a consistent no effect |
| Symptoms: no between group differences in whole population. No data for South Asian sub-group, but authors state that ‘intervention effect was not significant for other sub-group analysis’ | |||
| Process | Not assessed |
| |
| Behavioural, 2 m, 1 yr | [Note: these data are an | Illustrated as a consistent no effect | |
| Self-management behaviour: no between group differences in whole population. No data for South Asian sub-group, but authors state that ‘intervention effect was not significant for other sub-group analysis’ | |||
| Griffiths[ | Clinical-unscheduled care | Unscheduled care: there was no between group difference in healthcare use | Illustrated as a consistent no effect |
| aTime to first unscheduled contact FU: HR = 1.19 (0.92 to 1.53); | |||
| Proportion without unscheduled care FU: OR = 0.72 (0.45 to 1.16); | |||
| Time to first unscheduled primary care contact FU: HR = 1.20, 0.92 to 1.57 | |||
| Time to first routine review in primary care FU: HR = 2.22, 1.67 to 2.95 | |||
| Corticosteroid prescriptions: There was no between group difference in steroid prescriptions | |||
| Steroids FU: | |||
| FU: 3 m, 1 yr Overall risk of bias: low | Clinical-asthma control, 3 m, 1 yr | Asthma control: there was no between group difference in symptom score | Illustrated as a consistent no effect |
| Process, 3 m, 1 yr | Symptom score FU 1 yr: 9.9 (SD 5.0) vs. | ||
| Self-efficacy was improved at 3 m but not at 1 yr follow-up; | Illustrated as a consistent no effect. Another bar plotted to illustrate the 3 m finding—as a consistent significant positive effect | ||
| At 3 months: | |||
| At 12 months: | |||
| Behavioural | Not assessed | – | |
| Moudgil[ | Clinical-unscheduled care, not stated ISC: | [Note: these data are an | Illustrated as a consistent no effect |
| Number of asthma events/episodes for South Asians: no between group differences | |||
| aProportion with an admission. | |||
| Proportion with an A&E attendance. | |||
| Proportion with out-of-hours primary care. | |||
| Proportion with a GP consultation. | |||
| Proportion with a steroid course. | |||
| FU: 4 m, 8 m, 1 yr Overall risk of bias: High | Clinical-asthma control, 1 yr ISC | [Note: these data are an | Illustrated as a consistent significant positive effect |
| Quality of life in South Asians was significantly better in the intervention group | |||
| Change in AQLQ FU: | |||
| Process | Not assessed | – | |
| Behavioural | Not assessed | – | |
| Poureslami[ | Process, 3 m, 6 mPunjabi | [Note: these data are an | Insufficient data |
| aKnowledge: no comparison data for intervention and control groups | |||
| FU: 3 m, 6 m; 1 telephone survey interview Overall risk of bias: unclear | Behavioural, 3 m, 6 m | [Note: these data are an a priori sub-group analysis] | Insufficient data |
| Punjabi | Understanding physician instructions; on amedication and proper inhaler use skills: no comparison data for intervention and control groups | ||
| Blixen[ | Clinical-unscheduled care, 3 m, 6 m | Healthcare use: no data provided, though stated as no significant between group differences | Illustrated as a consistent no effect |
| Clinical-asthma control, 3 m, 6 m | Quality of life: There was no significant between group differences | Illustrated as a consistent no effect | |
| Overall AQOL score. FU 6 m: | |||
| FU: 3 m, 6 m Overall risk of bias: high | Process | Not assessed | – |
| Behavioural, 3 m, 6 m | Self-management behaviours: no data, though stated as no-significant between group differences | Illustrated as a consistent no effect | |
| Fisher[ | Clinical-unscheduled care, Quarterly for 3 yrs | aAcute care: no data given (results illustrated graphically), though authors stated no significant between group differences in acute care (hospitalisations and ED attendances | Illustrated as a consistent no effect |
| Clinical-asthma control | Not assessed | – | |
| FU: 3, 6, 9, 12, 16, 20, 24, 28, 32, 36 m Overall risk of bias: unclear | Process | Not assessed | – |
| Behavioural, Every quarterly until 3 yrs | aAsthma management: no significant between group differences in the non-validated assessment of parent’s reported attitude about asthma and asthma management | Illustrated as a consistent no effect | |
| Attitudes about asthma FU: | |||
| Appropriate thresholds for seeking help Baseline: | |||
| Fisher[ | Clinical-unscheduled care, 1 yr, 2 yr | aHospitalisation Compared to controls, the intervention group had fewer hospitalisations; | Illustrated as a consistent significant positive effect |
| Hospitalised at least once FU | |||
| FU: 6, 12, 18, 24 m Overall risk of bias: low | Clinical-asthma control | Not assessed | – |
| Process | Not assessed | – | |
| Behavioural | Not assessed | – | |
| Ford[ | Clinical-unscheduled care, 4 m, 8 m, 1 yr | aED visits No impact [Note: these data are an | Illustrated as a consistent no effect |
| ED visits/year I: Baseline: 5.0 (SD 3.6) vs. FU 2.7 (SD 3.3); | |||
| No between group comparisons reported | |||
| Clinical-asthma control, 4 m, 8 m, 1 yr | Limited days of activity No impact [Note: these data are an | ||
| Days/person: | |||
| FU: 4 m, 8 m, 1 yr Overall risk of bias: high | Process, 1 yr | aKnowledge and beliefs: no effect [Note: these data are an | Illustrated consistently no effect |
| Mean scores | |||
| No between group differences reported | |||
| Behavioural | Not assessed | – | |
| Keslo[ | Clinical-unscheduled care, 1 yr | Unscheduled care: compared to controls, the intervention reduced ED visits but not hospitalisations | Illustrated as a significant positive effect but hatched to show inconsistency |
| aChange in ED visits Baseline: | |||
| Change in hospitalisations Baseline: | |||
| FU: 1 yr, telephone every 2 wks to every 6 m Overall risk of bias: unclear | Clinical-asthma control | Not assessed | – |
| Process, After intervention | No data reported for knowledge | Insufficient data | |
| No data reported for medicine treatments | |||
| Behavioural | Not assessed | – | |
| Keslo[ | Clinical-unscheduled care, 1 yr, 2 yr | Unscheduled care: Intervention group had a greater reduction in hospitalisations and ED visits | Illustrated as a consistent significant positive effect |
| aChange in ED visits. Median (IQR) visits 2 years, | |||
| aChange in hospitalisations. Median (IQR) hospitalisations, | |||
| FU: every month then every 2–3 m Overall risk of bias: High | Clinical-asthma control 6 m, 1 yr, 18, 2 yr | No control group data reported for quality of life, asthma bother or peak flows | Insufficient data |
| Process, before and after intervention | No control group data reported for Knowledge control group | Insufficient data | |
| No control group data reported for medicine treatments control group | |||
| Behavioural | Not assessed | – | |
| Velsor-Friedrich[ | Clinical-unscheduled care, 2 wks, 5 m, 1 yr | Unscheduled care: the intervention group had significantly more unscheduled visits at 5 m and 1 yr | Illustrated as a consistent significant negative effect |
| Medical visits at 5 m. Mean (SE) | |||
| Medical visits at 1 yr. Mean (SE) | |||
| FU: 2 wks, 5 m, 1 yr Overall risk of bias: unclear | Clinical-asthma control, 2 wks, 5 m, 1 yr | Symptom days: greater reduction in days with symptoms in intervention compared to control | Illustrated as a consistent positive effect but hatched to show inconsistency |
| Symptom days at 5 m. Mean (SE). | |||
| Symptom days at 1 yr. Mean (SE). | |||
| PEFR: intervention group had greater increase in PEFR at both FU time-points | |||
| % increase in PEFR at 5 m. | |||
| % increase in PEFR at 1 yr. | |||
| School absences: no between group difference in days absent from school | |||
| Days absent at 1 yr. | |||
| Process, 2 wks, 5 m, 1 yr | Knowledge, self-efficacy and self-esteem/motivation: no significant between group differences | Illustrated as a consistent no effect | |
| Asthma knowledge test at 5 m: | |||
| Asthma belief survey at 5 m. | |||
| Self-perception inventory at 5 m. | |||
| Behavioural, 2 wks, 5 ms | Self-practice/asthma self-care: No significant between group differences | Illustrated as a consistent no effect | |
| Denyes self-care agency instrument at 5 m: 72.03 (SE 2.46) vs. 70.57 (SE 1.68) | |||
| Asthma self-care instrument at 5 m | |||
| Velsor-Friedrich[ | Clinical-unscheduled care, 2 wks, 5 m, 1 yr | Urgent medical visits (and medications): no significant between group differences at any time point | Illustrated as a consistent no effect |
| Urgent doctor visits at 12 m. | |||
| No data; some data on medicine use was provided | |||
| FU: 2 wks, 5m, 1 yr, 2 yr Overall risk of bias: unclear | Clinical-asthma control, 2 wks, 5 m, 1 yr, 2 yr | Symptoms, PEFR and school absences: no significant between group differences at any time point | Illustrated as a consistent no effect |
| Proportion with > 1 day with symptoms/2 wks at 1 yr. | |||
| % increase in PEFR from baseline at 1 yr. | |||
| Average days absent from school. | |||
| Process, 2 wk, 5 m, 12 m | Knowledge and self-efficacy: Intervention group had higher scores at all time-points, but neither group improved over time | Illustrated as a consistent positive effect but hatched to show inconsistency | |
| Asthma Knowledge: test at 1 yr. Adjusted mean | |||
| Asthma belief scale at 1 yr. Adjusted mean | |||
| Self-esteem: no significance between group differences at any time point | |||
| Self-perception inventory at 1 yr. Adjusted mean | |||
| Behavioural, 2 wks, 5 m, 1 yr | Asthma self-care practice/general self-care: intervention group had higher scores at all time-points, but neither group improved over time | Illustrated as a consistent positive effect | |
| Denyes self-care agency instrument. | |||
| General self-care. | |||
| Velsor-Friedrich[ | Clinical-Unscheduled care, 6 m, 12 m | Hospital visits: no significance between group differences | Illustrated as a consistent no effect |
| FU: 2 m, 6 m, 1 yr Overall risk of bias: high | Clinical-asthma control, 6 m, 1 yr | Symptoms reduced in both groups; no significant between group differences | Symptom takes priority. Illustrated as a consistent no effect |
| PEFR: no significance between group differences | |||
| School absences reduced in both groups; no significant between group differences | |||
| Process, 6 m, 1 yr | Knowledge, self-efficacy improved in both groups; no significant between group differences | Illustrated as a consistent no effect | |
| Coping frequency/efficacy, no significance between group differences | |||
| Behavioural, 6 m, 1 yr | Self-care practice, no significance between group differences | Illustrated as a consistent no effect |
For conflicting outcomes within a category, the decision process was dependent upon priority of evidence including:
• Defined primary outcomes in an adequately powered sample/sub-group analysis (for the latter we will consider a prior sub-group analysis)
• Outcomes measured using a validated instrument (as opposed to non-validated instruments)
• Outcomes that were clinically and statistically significant (e.g., achieved significance defined minimum clinically important difference)
• If doubts remain, the author’s interpretation was considered to provide context for the final decision
Note:
• For quality of life outcomes, we will use the overall score, if no overall score is stated the outcome will not be plotted
• Asthma related quality of life scales will be given priority (e.g., AQLQ) over generic quality of life scales (e.g., ED5D)
• For the clinical-asthma control category, symptoms will be a priority over other outcomes in the same category as it is a better indicator of asthma control
FU follow-up, wks weeks, m month, yr year, RCT randomised control trial, CCT clinical control trial, ED emergency department visits, I intervention, C control, CI confidence interval, AQLQ quality of life questionnaire, AQ20 the airways questionnaire 20, ACT asthma control test, F F statistics, AHR adjusted hazard ratio, HR hazard ratio, OR odds ratio, EES estimated effect size, PEFR peak expiratory flow rate, SD standard deviation, SE standard error, DF degree of freedom, p p-values
Fig. 2Harvest plots illustrating the effectiveness on clinical, process and behavioural outcomes of self-management interventions across different ethnic groups and social contexts. To determine the overall effectiveness of trials, plots were placed under each category (unscheduled care, asthma control, process or behavioural), according to whether findings were positive (i.e., interventions, which were significantly effective in the intervention group), negative (i.e., interventions, which were significantly effective in the control group), or outcomes that had no impact between groups.[50] The colours of the plots in the graph represent the study length (long and/or short), the height of the bars represent the sample size and the icon on the top of the bars represent the overall risk of bias within studies
Fig. 3Summary of identified barriers and facilitators to asthma self-management in interventions across different groups
Search strategy terms
| Asthma | Self-management | Population search |
|---|---|---|
| Asthma | Self management OR asthma control OR self care | South Asians |
| Barriers OR facilitators | Bengali OR Bangladeshi OR Bangladesh | |
| Beliefs OR attitudes | Indian OR India | |
| Knowledge OR asthma education | Pakistani OR Pakistan | |
| Black OR African OR Afro Caribbean | ||
| Ethnic OR ethnicity |
PICO search strategy
| PICO | Criteria |
|---|---|
| Population | South Asian communities (Indian, Pakistani, Bangladeshi etc.), or Black populations (African, Caribbean or Other) asthma patients, their parents/carers, healthcare or lay professionals. The search considered all population ages and countries |
| Intervention | Asthma self-management interventions in any healthcare, community or remote settings. We used the self-management definition of the US Institute of Medicine: |
| Comparator | Asthma patients, parents/carers of children with asthma, healthcare or lay professionals supporting asthma patients, who did not receive asthma self-management intervention |
| Outcomes | Outcomes of interest were:1. Clinical outcomes: (i) current asthma control was defined as the degree to which different asthma manifestations were reduced/eliminated by treatment. Here, main categories include clinical-asthma control level (ii) future risk of adverse events and unscheduled healthcare utilisation. All clinical outcomes are aligned with the American Thoracic Society/European Respiratory Society Task Force standardised definitions[ |
| Exclusion | 1. All studies that did not explicitly specify population were excluded e.g., trials that did not provide details on which ethnic group they are referring to when they used broad terms such as ‘West Indians’ or ‘Asians’2. Studies of multiple ethnic populations that did not provide outcome data separately for the South Asian and the Black ethnic groups or subgroups were excluded3. Trials studying multiple illnesses but did not provide separate outcome data for asthma were excluded |